Breast Cancer :: Avastin in Europe for women with metastatic breast cancer
Roche announced that their innovative cancer drug Avastin (bevacizumab) has been approved in Europe for the treatment of women with metastatic breast cancer.
Roche announced that their innovative cancer drug Avastin (bevacizumab) has been approved in Europe for the treatment of women with metastatic breast cancer.
A WHO background document will be used to help guide discussions and stir debate. The paper profiles eight issues linked to international health security, together with key points to focus the debate:
In response to the urgent need to reduce the number of new HIV infections globally male circumcision should be recommended for the prevention of HIV infection.
New genetic markers may be able to predict whether a person is likely to have coronary heart disease (CAD) in the future.
Protein degradation and malfunction is a major cause of ageing and can be the result of attacks on proteins by other molecules. One of these processes, called glycation, involves the spontaneous attack by sugars on proteins.
Scientists at Dana-Farber Cancer Institute have shown in a laboratory study that revving up a crucial set of muscle genes counteracts the damage caused by a form of muscular dystrophy.
The sixth meeting of the ICCDE – International Commission for the Certification of Dracunculiasis (guinea-worm disease) Eradication – was held 5 to 7 March at WHO headquarters in Geneva.
Singapore Prime Minister Lee Hsien Loong said “The theme of this year’s World Health Day, international health security, is apt given the global health landscape today. In a highly interconnected world, diseases spread fast and recognize no boundaries.”
Roche and CuraGen announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing.
French CNRS scientists in collaboration have shown that a memory of a traumatic event can be wiped out, although other, associated recollections remain intact.